/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.05%
Natural Gas
-1.31%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.32%
VIX
N/A
Economic Calendar
EUR/USD
+0.05%
Natural Gas
-1.31%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.32%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
October Retail Sales Rise 0.4%, Show Resilience Despite Slowing Momentum
3 days ago
China Retail Sales Jumps in October as Unemployment Drops to 5.0%
3 days ago
France’s Economic Strengths Balance Increasingly Challenging Fiscal, Political Outlooks
4 days ago
Crude Inventories Rise By 2.1 Million Barrels, Exceeding Analyst Estimates
4 days ago
October PPI Rises 0.2%, Supporting Fed Rate Cut Hopes as Inflation and Jobs Steady
4 days ago
Disney’s Streaming Fuels Optimism; PPI Data May Forecast Fed’s Next Steps
4 days ago
Earnings in Focus: How Lowe’s, Target, and Nvidia Navigated Q3 Challenges
11 minutes ago
Silver (XAG) Forecast: Will Dollar Weakness Spark a Rebound?
23 minutes ago
Gold News: Resistance at $2604 Holds the Key to the Next Price Breakout
about 1 hour ago
Oil News: Tensions in Ukraine Drive Crude Oil Higher Amid Bearish Market Sentiment
about 1 hour ago
Cryptocurrency Market Analysis: Altcoins Gain Momentum
about 2 hours ago
US Dollar Price Forecast: G20 Meetings in Focus: Gold, GBP/USD, and EUR/USD Outlook
about 3 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
AMRX
news
Amneal Pharmaceuticals Inc - Class A
Follow
AMRX
(
Nasdaq - US
)
Closed
8.48
-0.52 (-5.83%)
in
:
usd
•
As of: Nov 15, 2024 15:59
UTC -5
Pre Market
:
0
+0.00 (0.00%)
Open
8.92
High
8.97
Low
8.38
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Latest News
Zacks Investment Research
Nov 6, 2024
Amneal (AMRX) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
AMRX
-5.83%
Zacks Investment Research
Nov 5, 2024
5 Stocks Backed by High Efficiency for Solid Gains Amid Volatility
APH
-2.83%
Zacks Investment Research
Nov 1, 2024
Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to Decline
AMRX
-5.83%
Zacks Investment Research
Oct 15, 2024
How to Find Great Cheap Stocks Under $10 to Buy in October
AMRX
-5.83%
Zacks Investment Research
Oct 14, 2024
Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year?
AMRX
-5.83%
Zacks Investment Research
Sep 3, 2024
Amneal Stock Rises 29% in a Month on Upbeat Regulatory Updates
AMRX
-5.83%
Zacks Investment Research
Aug 21, 2024
Despite Fast-paced Momentum, Amneal (AMRX) Is Still a Bargain Stock
AMRX
-5.83%
Zacks Investment Research
Aug 16, 2024
5 Small Drug Stocks to Buy as Innovation Reaches Peak
CORT
-5.40%
Seeking Alpha
Aug 9, 2024
Amneal Pharmaceuticals, Inc. (AMRX) Q2 2024 Earnings Call Transcript
AMRX
-5.83%
Zacks Investment Research
Aug 9, 2024
Compared to Estimates, Amneal (AMRX) Q2 Earnings: A Look at Key Metrics
AMRX
-5.83%
Zacks Investment Research
Aug 9, 2024
AMNEAL PHARMACEUTICALS, INC. (AMRX) Soars to 52-Week High, Time to Cash Out?
AMRX
-5.83%
Zacks Investment Research
Aug 9, 2024
Amneal Pharmaceuticals (AMRX) Beats Q2 Earnings and Revenue Estimates
AMRX
-5.83%
Zacks Investment Research
Aug 7, 2024
Wall Street's Insights Into Key Metrics Ahead of Amneal (AMRX) Q2 Earnings
AMRX
-5.83%
Zacks Investment Research
Aug 2, 2024
Earnings Preview: Amneal Pharmaceuticals (AMRX) Q2 Earnings Expected to Decline
AMRX
-5.83%
Zacks Investment Research
Jul 29, 2024
Amneal Pharmaceuticals (AMRX) is a Great Momentum Stock: Should You Buy?
AMRX
-5.83%
Zacks Investment Research
Jul 29, 2024
Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year?
AMRX
-5.83%
Zacks Investment Research
Jul 29, 2024
Amneal (AMRX) Is Attractively Priced Despite Fast-paced Momentum
AMRX
-5.83%
Seeking Alpha
Jul 10, 2024
Amneal Pharmaceuticals: Maintaining Momentum Is Key To Success
AMRX
-5.83%
Seeking Alpha
May 3, 2024
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2024 Earnings Call Transcript
Zacks Investment Research
May 3, 2024
Amneal (AMRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker